Assessment of tubulin mutations in a phase II study of biweekly gemcitabine/paclitaxel (T) in advanced non-small-cell lung cancer (NSCLC)
Rosell, R, O'Brate, A, Sánchez, J, Isla, D, Felip, E, Camps, C, González-Larriba, J.L, Antón, A, Carrato, A, Azagra, P, Alberola, V, Massuti, BVolume:
29
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/s0169-5002(00)80159-2
Date:
September, 2000
File:
PDF, 114 KB
english, 2000